Blog

Immunotherapy drug nearly eliminates severe acute graft-versus-host disease – Science Daily

Immunotherapy drug nearly eliminates severe acute graft-versus-host disease
Science Daily
"Given the serious threat of graft-versus-host disease, new approaches to make stem cell transplants safer for patients remain a critical unmet need," said Dr. Leslie Kean, the trial's principal investigator and associate director of the Ben Towne

and more »

2017-12-12 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.